Ranked by rounds participated in, from announcements across all periods. Lead counts include only confirmed lead roles.
New companies 21 · Follow-on 2
Stages: Series A 8, Series C+ 6, Series B 5, Seed 3, Undisclosed 1
Baba $40M Series ADisha (formerly Curelink) ₹438.8M Series AThatch $108M New fundingNew companies 21 · Follow-on 0
Stages: Series A 8, Series C+ 5, Series B 4, Seed 3, Undisclosed 1
Vitalize $31M Series AAngle Health $200M Series C and tender offerMetriport $26M Series ANew companies 13 · Follow-on 0
Stages: Seed 4, Series B 4, Series A 2, Undisclosed 2, Series C+ 1
MintNeuro $5M UndisclosedEvvy $40M Series BHopscotch Primary Care $53M Series DNew companies 12 · Follow-on 0
Stages: Series C+ 4, Series A 3, Undisclosed 3, Seed 1, Series B 1
Sharp Performance $18M Series AGeneral Medicine $120M Series BDevoted Health $555M Series GNew companies 11 · Follow-on 0
Stages: Series B 4, Series C+ 4, Seed 1, Series A 1, Undisclosed 1
Even Healthcare $50M Series BAbby Care $82M Series CRightway $155M Series ENew companies 10 · Follow-on 0
Stages: Series C+ 3, Series A 2, Series B 2, Undisclosed 2, Growth 1
Allara $30M FundingLifeMine Therapeutics $263M Series D+Series EContraline $92.5M Series BNew companies 9 · Follow-on 1
Stages: Seed 3, Series C+ 3, Undisclosed 3, Series A 1
Allara $30M FundingThatch $108M New fundingFerry Health $9M SeedNew companies 9 · Follow-on 0
Stages: Series A 5, Series B 2, Seed 1, Series C+ 1
Suki $90M Series EKairon Health $5M SeedGenHealth.ai $16.5M Series ANew companies 9 · Follow-on 0
Stages: Series A 3, Series B 2, Undisclosed 2, Growth 1, Series C+ 1
LifeMine Therapeutics $263M Series D+Series ECelea Therapeutics $180M GrowthOllin Biosciences $330M Series BNew companies 8 · Follow-on 0
Stages: Series C+ 5, Series A 1, Series B 1, Undisclosed 1
Sirona Medical $40M Series DHopscotch Primary Care $53M Series DCandid Health $120M Series DNew companies 8 · Follow-on 0
Stages: Series A 2, Series C+ 2, Undisclosed 2, Seed 1, Series B 1
Abby Care $82M Series CBasalt Health $20M Series AThyme Care >$125M Series ENew companies 7 · Follow-on 1
Stages: Series C+ 6, Series A 1, Series B 1
Abby Care $82M Series CRightway $155M Series EForus $150M Series CNew companies 7 · Follow-on 1
Stages: Seed 3, Series C+ 3, Series A 1, Series B 1
General Medicine $120M Series BCorridor $25M SeedFerry Health $9M SeedNew companies 8 · Follow-on 0
Stages: Series C+ 3, Series A 2, Series B 2, Undisclosed 1
Vitalize $31M Series ACandid Health $120M Series DCorner Health $32.5M Seed+Series ANew companies 8 · Follow-on 0
Stages: Undisclosed 3, Seed 2, Series A 2, Series C+ 1
Epsilon Health $27.6M FundingThyme Care >$125M Series EPearl Health $110M Equity+DebtNew companies 7 · Follow-on 0
Stages: Series C+ 3, Series A 2, Undisclosed 2
Baba $40M Series AAbby Care $82M Series CThyme Care >$125M Series ENew companies 7 · Follow-on 0
Stages: Series C+ 4, Seed 1, Series B 1, Undisclosed 1
Abby Care $82M Series CHealthleap $8M SeedBunkerhill Health $25M Series BNew companies 7 · Follow-on 0
Stages: Undisclosed 3, Series A 2, Series B 1, Series C+ 1
Tiny Health $33M Series BMoneyStack $1M UndisclosedConcordare Trials Undisclosed UndisclosedNew companies 7 · Follow-on 0
Stages: Series A 2, Series B 2, Series C+ 2, Seed 1
Flagler Health $50M Series BBlank Bio $7.2M SeedQualified Health $125M Series BNew companies 7 · Follow-on 0
Stages: Series B 3, Series A 2, Undisclosed 2
LifeMine Therapeutics $263M Series D+Series EOllin Biosciences $330M Series BCity Therapeutics $99.5M Series BNew companies 6 · Follow-on 0
Stages: Seed 4, Pre-seed 1, Series A 1
Metabolize $3.2M SeedCradlewise $12M Series ATippingPoint Biosciences $4.5M SeedNew companies 6 · Follow-on 0
Stages: Series A 2, Series B 2, Series C+ 2
Abby Care $82M Series CSolstice $21M Series ALatent $80M Series ANew companies 6 · Follow-on 0
Stages: Undisclosed 4, Growth 1, Series C+ 1
HighLife €80M Financing roundMMI €17M €17 million co-investmentTensive ≤€20M Convertible venture debtNew companies 6 · Follow-on 0
Stages: Series A 2, Series C+ 2, Seed 1, Undisclosed 1
HighLife €80M Financing roundBionyra Pharma $165M Series ACellCentric $220M Series DNew companies 6 · Follow-on 0
Stages: Series C+ 3, Seed 1, Series B 1, Undisclosed 1
Angle Health $200M Series C and tender offerThyme Care >$125M Series EHopscotch Primary Care $53M Series DNew companies 6 · Follow-on 0
Stages: Series C+ 3, Series A 2, Series B 1
Thyme Care >$125M Series EKhartis Therapeutics $50M Series BStepful $55M Series CNew companies 6 · Follow-on 0
Stages: Series A 2, Undisclosed 2, Growth 1, Series C+ 1
Leal Therapeutics $30M Series ATytoCare >$25M GrowthAccro Bioscience $50M Series CNew companies 6 · Follow-on 0
Stages: Series A 3, Series B 2, Undisclosed 1
Bunkerhill Health $25M Series BAmigo AI $11M Series AGreater Good Health $20.5M Series BNew companies 6 · Follow-on 0
Stages: Series C+ 3, Series B 2, Series A 1
Neko Health $700M Series CAssort Health $120M Series CTriomics $22M Series BNew companies 6 · Follow-on 0
Stages: Series C+ 2, Pre-seed 1, Series A 1, Series B 1, Undisclosed 1
Syntax Bio $14.4M Series A+Techcyte $15M UndisclosedSub-Q Bionics $1.5M Pre-Seed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.